Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2150.70

-12.15 (-0.56%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2150.70

-12.15 (-0.56%)
16:02 Dec 20

Quality

84/100
High Financial Strength

Valuation

39/100
Mid Valuation

Technical

65/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	15162.96	16405.48	16641.66	20010.82	21431.26
Operating Expenses +	12596.08	16118.26	14843.54	16200.3	16815.14
Raw Material	5847.1	6679.56	6626.03	7100.91	7102.77
Increase Decrease in Cost	-484.86	-198.32	153.73	-457.44	-368.35
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	2825.9	2989.3	3087.15	3494.57	3768.02
Miscellaneous Expenses	9762.56	13535.42	10853.07	11979.7	6312.7
Operating Profit	2566.88	287.22	1798.12	3810.52	4616.12
Other Income	136.29	141.69	73.36	120.17	168.69
Depreciation	887.41	1658.71	880.69	1196.81	1218.93
Interest	140.64	142.77	274.3	311.61	284.18
Profit before tax and exceptio..	1675.12	-1372.57	716.49	2422.27	3281.7
Exceptional Items	0	0	0	0	0
PBT	1675.12	-1372.57	716.49	2422.27	3281.7
Provision for Taxation	448.52	137.15	268.8	486.7	629.76
Net Profit	1226.6	-1509.72	447.69	1935.57	2651.94
NET Profit after MI	1216.53	-1528.04	430.08	1914.48	2626.49
EPS	26.72	-33.65	9.41	41.87	57.64
Operating Profit Margin (%)	16.93	1.75	10.8	19.04	21.54
Net Profit Margin (%)	8.02	-9.31	2.58	9.57	12.26

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	47.00	47.00	47.00	47.00	47.10
FII	21.50	19.30	18.30	16.10	15.00
MF	16.90	16.20	16.80	18.90	16.70
Public	6.40	6.90	6.90	7.10	8.50
Others	0.00	0.00	0.00	0.10	0.00
Others	8.20	10.60	11.00	10.80	12.70